Furthermore, localized treatment with anti–TNF-α neutralizing antibody rescued the β-catenin–activated AM pro-metastatic phenotype, and this β-catenin/TNF-α axis was observed in the AMs of patients with lung cancer . This evidence concerns the gene TNF and lung cancer.